PRESS RELEASE published on 08/14/2026 at 07:00, 3 months 7 days ago Pfizer et Valneva annoncent l’acceptation pour revue par l’Agence européenne des médicaments (EMA) de la demande d’autorisation de mise sur le marché de leur candidat vaccin contre la maladie de Lyme Pfizer et Valneva soumettent leur candidat vaccin hexavalent contre la maladie de Lyme à l'examen de l'EMA. Le vaccin PF-07307405 présente une efficacité de plus de 70 % selon l'étude VALOR Valneva Maladie De Lyme Pfizer Vaccin EMA
PRESS RELEASE published on 08/14/2026 at 07:00, 3 months 7 days ago Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency European Medicines Agency validates Pfizer and Valneva's MAA for Lyme Disease Vaccine Candidate based on Phase 3 results. Potential game-changer in Lyme disease prevention Valneva Lyme Disease Vaccine Pfizer European Medicines Agency Phase 3 VALOR Trial
PRESS RELEASE published on 08/13/2026 at 07:00, 3 months 8 days ago Valneva publie ses résultats financiers du premier semestre 2026 et fait un point sur ses activités
PRESS RELEASE published on 08/13/2026 at 07:00, 3 months 8 days ago Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates Valneva SE reports half-year 2026 financial results, maintains full-year guidance, strengthens cash position, and provides corporate updates. Live webcast of results conference call available Financial Results Revenue Valneva SE Half-year Corporate Updates
BRIEF published on 07/22/2026 at 17:50, 3 months 29 days ago Valneva annoncera ses résultats financiers du premier semestre 2026 Résultats Financiers Webdiffusion Déclarations Prospectives Développement Des Vaccins Approbations Du Marché
BRIEF published on 07/22/2026 at 17:50, 3 months 29 days ago Valneva to Announce First Half 2026 Financial Results Financial Results Forward-looking Statements Webcast Vaccine Development Market Approvals
PRESS RELEASE published on 07/22/2026 at 17:45, 3 months 29 days ago Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026 Valneva SE to report First Half 2026 Consolidated Financial Results on August 13, 2026. The live webcast will discuss financial results and provide a business update Financial Results Business Update Valneva SE Live Webcast Vaccine Company
BRIEF published on 06/25/2026 at 17:50, 4 months 25 days ago Valneva confirme des changements de direction lors de l'assemblée générale annuelle Assemblée Générale Annuelle Valneva SE Changement De Leadership Résolutions Des Actionnaires Gouvernance Biopharmaceutique
BRIEF published on 06/25/2026 at 17:50, 4 months 25 days ago Valneva Confirms Leadership Changes at Annual General Meeting Annual General Meeting Leadership Change Valneva SE Shareholder Resolutions Biopharmaceutical Governance
Published on 11/20/2026 at 15:00, 20 hours 49 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 20 hours 59 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 21 hours 49 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 22 hours 19 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 22 hours 19 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 12 hours 3 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 13 hours 9 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 14 hours 12 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 14 hours 59 minutes ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 17 hours 14 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 17 hours 14 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 18 hours 14 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 18 hours 14 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 16 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR